Literature DB >> 698108

The effect of topical isoprenaline on psoriatic skin.

N S Das, T N Chowdary, C Sobhanadri, K V Rao.   

Abstract

Twelve patients with psoriasis were treated by the topical application of 0.1% isoprenaline sulphate ointment for 10 days. Topical white vaseline was used as a control in three patients with psoriasis. The mean glycogen level was found to be decreased significantly (from 120 +/- s.d. 40 to 58 +/- s.d. 26 mg/100 g of wet weight of involved skin) after topical application of 0.1 isoprenaline sulphate and the scaling also disappeared. Topical application of white vaseline did not produce any significant change in glycogen levels or scaling. The changes after isoprenaline application may have been due to an increase in the ratio of cyclic AMP/cyclic GMP which inhibited cell turnover and increased glycogenolysis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 698108     DOI: 10.1111/j.1365-2133.1978.tb01982.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.

Authors:  K Asadullah; W Sterry; K Stephanek; D Jasulaitis; M Leupold; H Audring; H D Volk; W D Döcke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  The use of indentometry to study the effect of agents known to increase skin c-AMP content.

Authors:  A Hartzshtark; S Dikstein
Journal:  Experientia       Date:  1985-03-15

3.  A Tissue-Engineered Human Psoriatic Skin Model to Investigate the Implication of cAMP in Psoriasis: Differential Impacts of Cholera Toxin and Isoproterenol on cAMP Levels of the Epidermis.

Authors:  Mélissa Simard; Sophie Morin; Geneviève Rioux; Rachelle Séguin; Estelle Loing; Roxane Pouliot
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.